Projects per year
Personal profile
Education
- 2007 亞利桑那大學藥事經濟博士
- 2003 伊利諾大學芝加哥分校藥學管理碩士
- 1999 臺灣大學藥學系學士
Experience
- 2020- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2020- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2016- Director, Research Center of Pharmacoeconomics, College of Pharmacy, Taipei Medical University
- 2015-2020 Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2015-2020 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2009-2014 Assistant Professor, University of Singapore
- 2007-2009 Postdoctoral researcher, University of Singapore
Research Interests
- 藥事經濟暨效果研究
- 用藥安全
- 心理計量學
- 健康照護服務研究
Fingerprint
Dive into the research topics where Yu Ko is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
建置常見疾病的本土藥物經濟模型並運用醫療科技評估方法探討健保給付醫療措施之效益
1/23/17 → 12/31/19
Project: A - Government Institution › f - Other (Funded by Government)
-
Outcomes research in gout: economic impact, humanistic burden, and pharmacoeconomic evaluation
1/1/16 → 12/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
-
104年度科學及技術類委託研究計畫「健保已給付新藥副作用之風險評估_以口服抗凝血劑為例」計畫案
Chien, L., Ko, Y., Chien, S. & Chi, N.
12/23/15 → 12/22/16
Project: A - Government Institution › c - Ministry of Health and Welfare
-
Febuxostat 和 Allopurionol 用於慢性腎臟病病人的成本效益分析
5/1/15 → 4/30/17
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
An investigation of physicians' prescribing behaviors related to antidiabetic agents for Type 2 diabetes mellitus patients and associated factors in Taiwan
Chen, X., Wang, C. Y. & Ko, Y., 2022, (Accepted/In press) In: Current Medical Research and Opinion.Research output: Contribution to journal › Article › peer-review
-
Effectiveness and cost-effectiveness of trastuzumab emtansine in women with HER2-positive locally advanced or metastatic breast cancer: A systematic review and meta-Analysis
Yeh, Y., Chen, C. & Ko, Y., Jul 1 2022, In: Journal of Cancer Research and Therapeutics. 18, 4, p. 1061-1072 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness of Botulinum Toxin Type A Injection on Scars: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Li, M. Y., Chiu, W. K., Wang, H. J., Chen, I. F., Chen, J. H., Chang, T. P., Ko, Y. & Chen, C., Dec 1 2022, In: Plastic and Reconstructive Surgery. 150, 6, p. 1249E-1258EResearch output: Contribution to journal › Review article › peer-review
-
Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: The REMIND-TMU study
Chen, C. C., Ko, Y., Chen, C. H., Hung, Y. J., Wei, T. E., Chang, T. H., Ke, S. S., Kuo, K. N. & Chen, C., Nov 2022, In: American Journal of the Medical Sciences. 364, 5, p. 575-582 8 p.Research output: Contribution to journal › Article › peer-review
-
Talent cultivation in health technology assessment: an expert survey
Wu, Y. S., Chen, C., Wang, L. C., Jian, L. S. & Ko, Y., Mar 8 2022, In: BMC Medical Education. 22, 1, p. 157 157.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
Patient preferences for diabetes-related complications in Taiwan
Ko, Y. (Creator), Cheng, S. (Contributor), Lin, Y. (Contributor) & Wang, C. (Contributor), Taylor & Francis, 2018
DOI: 10.6084/m9.figshare.6194663.v1, https://doi.org/10.6084%2Fm9.figshare.6194663.v1
Dataset
-
Talent cultivation in health technology assessment: an expert survey
Wu, Y. (Creator), Chen, C. (Creator), Wang, L. (Creator), Jian, L. (Creator) & Ko, Y. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5883829.v1, https://springernature.figshare.com/collections/Talent_cultivation_in_health_technology_assessment_an_expert_survey/5883829/1
Dataset
-
Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
Chen, Y. (Contributor), Chien, C. (Contributor), Peng, Y. (Contributor), Malone, D. C. (Creator) & Ko, Y. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.12871744.v1, https://doi.org/10.6084%2Fm9.figshare.12871744.v1
Dataset